Greenville, South Carolina, March 17, 2023 (GLOBE NEWSWIRE) -- ARCpoint Inc. (TSXV:ARC) (the “Company” or “ARCpoint”), announces accelerated release of 1,923,000 Class A Subordinate Voting Shares of the Company (the “Released Shares”) registered in the name of GICMB Venture Corp. I (“GVC”) from the transfer restrictions set out in the lock-up agreement (the “Lock-up Agreement”) voluntarily entered into by GVC on October 21, 2022. GVC is an arm’s length party to the Company. The Released Shares w
Greenville, South Carolina, March 08, 2023 (GLOBE NEWSWIRE) -- ARCpoint Inc. (TSXV: ARC) (the “Company” or “ARCpoint”) a leading US-based franchise system and healthcare company providing drug testing, alcohol screening, DNA and clinical lab testing services announced today that it is undertaking a realignment of its business units and operations to effect cost savings, given reduced revenues and better align its structure with business development activities. ARCpoint CEO, John Constantine comm
Greenville, South Carolina, Nov. 15, 2022 (GLOBE NEWSWIRE) -- ARCpoint Inc. (TSXV: ARC) (the “Company” or “ARCpoint”) a leading US-based franchise system providing drug testing, alcohol screening, DNA and clinical lab testing services announced today that it expects to release financial results for the third quarter of 2022 before the market open Monday, November 28, 2022. The Company will host a conference call on Monday November 28, 2022 at 12:00 pm Eastern Time to review the results for the Q